Dr. Raymon H. Grogan is a board-certified surgeon currently serving as Section Chief of Endocrine Surgery at Baylor St. Luke’s Medical Center. He has helped co-author several national guidelines in the area of endocrine surgery and is a well-respected surgeon nationally. In addition to having expertise in the traditional surgical approaches to thyroid, parathyroid, adrenal, and endocrine pancreas diseases, Dr. Grogan is a pioneer of several novel techniques for operating on the thyroid and parathyroid. He is one of only a few experts in the United States on transoral endocrine surgery, a novel approach to surgery for both thyroid and parathyroid disease that leaves no visible scar. Dr. Grogan was one of the first surgeons to perform this operation in the United States and the first surgeon to perform this operation in the Midwest and in Texas. He also has experience in innovative minimally invasive thyroid, parathyroid, and adrenal surgery. Dr. Grogan is originally from Florida and began his training as an undergraduate at Emory University in Atlanta, followed by medical school at the University of Miami. He continued his training with a surgical internship in New York and a research fellowship in microvascular surgery at New York University. He then went on to General Surgery Residency training at Stanford University, followed by research and clinical fellowships in Endocrine Surgery at the University of California San Francisco, a fellowship program widely considered to be one of the best in the world. After this training, Dr. Grogan took his first faculty position as part of the prestigious endocrine surgery unit at the University of Chicago, where he was Director of the Endocrine Surgery Research Program, Director of the Endocrine Surgery Fellowship Program, Associate Program Director of the General Surgery Residency Program, and Chair of the Resident Research Advisory committee. During his tenure in Chicago, Dr. Grogan traveled abroad to Bangkok, Thailand to learn the Transoral Thyroidectomy technique from the world’s expert, Dr. Angkoon Anuwong, and then returned to Chicago and started the transoral endocrine surgery program. In addition to his work as a full-time clinical surgeon, Dr. Grogan also runs a well-known translational research program. He has a Master of Science in Public Health with a focus on epidemiology and biostatistics. He is the Principal Investigator and founder of the North American Thyroid Cancer Survivorship Study, which is a longitudinal cohort study that currently has nearly 3,000 participants enrolled and continues to expand. Through this work, Dr. Grogan has published several novel findings related to thyroid cancer survivorship and has helped start a national discussion on ways to improve quality of life for these patients. Dr. Grogan has also published several papers on health outcomes related to endocrine surgery and translational papers on the genetics and epidemiology of endocrine diseases. Most recently, Dr. Grogan has begun research on the relationship between the human microbiome and thyroid disease. In 2017, he was awarded the prestigious Paul LoGerfo Research Grant from the American Association of Endocrine Surgeons to study this relationship.
Years of Experience: 7
- University of Miami School of Medicine
If this is an emergency, dial 9-1-1 or go to the nearest emergency department.